1 |
Butenas S, Ribarik N, Mann KG. Synthetic substrates for human factor VIIa and factor VII atissue factor. Biochemistry. 1993 ; 32 : 6531-8.
DOI
ScienceOn
|
2 |
Quick J. The prothrombin in haemophilia and in obstructive jaundice. Journal of Biological Chemistry. 1935.
|
3 |
Han YN, Baik SK, Kim TH, Han BH. Antithrombotic activities of saponins from Ilex pubescens. Archives of Pharmacal Research. 1987 ; 10 : 115-22.
DOI
|
4 |
Berry CN, GirardD, Lochot S, Lecoffre C. Antithrombotic actions of argatrobas in rat medels of venous, mixed and arterial thrombosis, and its effects on the tail transection bleeding time. Br J Pharmacol. 1994; 113 : 1209-14.
DOI
ScienceOn
|
5 |
Park EH, Shin MJ. Anti-inflammatory Activity of Aqueous Extract from Gleditsiae Spina. Yakhak Hoeji. 1993; 37(2) : 124-8.
|
6 |
Simon MF, Lamnt V, Lachachi H, Plantavid M, Mauco G, Chap H, Douste-blazy L. PAF Metabolism and signalling process inhibition by ginkolides. Gingkolides (Braguet P ed). JR Prous barcelona. 1988 ; 127(1).
|
7 |
Kim CH, Hah DS, Leu JD, Heo JH, Jung MH, Choe YT, Kim GS, Kim JS. Oral Toxicity Studies for 2 weeks of Gleditschia-saponin in Sprague Dawley Rats. Journal of toxicology and public health. 2002 ; 18(3) : 285-92.
|
8 |
Lee SK, Shin JI, Seo UK, Jeong JC. A Study on Activities of Antioxidant and Antimutagenecity of the Extracts from Gleditsia sinensis. Journal of Korean oriental internal medicine. 2001 ; 22(2) : 215-22.
|
9 |
Kang SY, Cho KW, Han JH, Cho NG. Effect of Gleditsiae Spina on Hep G2 cells cytotoxicity and Apoptosis and No. Journal of Korean oriental internal medicine. 1997 ; 18(1) : 48-61
|
10 |
Park YK, Kang BS, Kim JT, Park IS, Ahn SH. The Experimental Study on Antitumor effects of Gleditsia spina. Journal of Herbology. 1997 ; 12(1) : 53-66.
|
11 |
Koltai M, Tosaki A, Guillon JM, Hrosford D Braguet. PAF antogonists as potential therapeutic agents in cardiac anaphylaxia and myocardial ischaemia. Cardiovasc Drug Rev. 1989 ; 77(7).
|
12 |
Gwak HS, Chun IK. Performulation study of aspalatone, a new antithrombotic agent. Journal Appl Pharmaclo. 2000 ; 8 : 332-7.
|
13 |
Hsieh KH. Thrombin interaction with fibrin with polymerization sites. Thrombosis Research. 1997 ; 86 : 301-16.
DOI
ScienceOn
|
14 |
Oriental medical university herbal medicine the National History Compilation Committee. Clinical Traditional Herbalogy. Seoul : Younglimsa. 2006 : 305
|
15 |
Verstraeta M, Lijnen HR, Collen D. Thrombolytic agents in development. Drugs. 1995 ; 50 : 29-42.
DOI
ScienceOn
|
16 |
Akkerman JWN. Interaction between the PAF receptor and fibirinogen binding sites on human platelets. In : Gingkolide (Braquet P ed). JR Prous barcelona. 1998 ; 93(1).
|
17 |
Katira R, Chauhan A, More RS. Direct thrombin inhibitors: novel abtithrombotics on the horizon in the thrombo prophylactic management of atrial fibrillation. Postgraduate Medical Journal. 2005 ; 81 : 370-5.
DOI
ScienceOn
|
18 |
Cattaneo F, Trento F, Pescador R, Porta R, Furro L. Pharmacodynamics of the antociagulant activity (APTT) of an algal polysaccharide. Thrombosis Research. 2002 ; 105 : 455-7.
DOI
ScienceOn
|
19 |
Molina V, Arruzazabala ML, Mas CR. Synergistic effect of D-003 and aspirin on experimental thrombosis models. Prostaglandins, Leukotrienes and Essential Fatty Acids. 2003 ; 68 : 305-10.
DOI
ScienceOn
|